UNSPSC 51433911: Teludipine

This classification denotes a calcium channel blocker with the molecular formula C28H38N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z9OJ72BM3O, chemically known as 3,5-pyridinedicarboxylic acid, 2-((dimethylamino)methyl)-4-(2-(3-(1,1-dimethylethoxy)-3-oxo-1-propenyl)phenyl)-1,4-dihydro-6-methyl-, diethyl ester, (e)- but generally known as teludipine, which bears US NIH Compound Identifier 6436165.

UNSPSC 51433911 Teludipine, a Commodity code, reflects state and local procurement of emergency and acute-care medications through direct-purchase and cooperative agreements. Recent opportunities show state and local governments buying advanced life support medications—including specific agents like labetalol, epinephrine, adenosine, and diltiazem—for fire rescue services and pharmacy benefit programs. The issuing bodies include municipal purchasing departments (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance / MMCAP). Scope ranges from individual unit purchases for emergency medical services to manufacturer-direct contracting agreements supporting state pharmacy benefit initiatives and cooperative multi-jurisdiction distribution networks. Work is solicited as sealed bids, RFPs, and requests for information; recent notices emphasize firm pricing inclusive of shipping, expiration-date warranties (typically nine months to one year from acceptance), rapid delivery (ten calendar days or less), and compliance with cGMP, DSCSA, FDA requirements, and OSHA hazard communication standards.

Activity appears across Florida, Texas, Minnesota, and participating cooperative member states including Oregon. The City of Tampa's IFB for Advanced Life Support Medications (26P00188, due April 8, 2026, estimated value $40,000) solicited four specific medication line items for Tampa Fire Rescue with a one-year term and renewal options, awarded to the lowest responsive bidder within 120 days, with a 5 percent SLBE bid discount available. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 (due March 26, 2026) to establish multi-award contracts for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson), with contract effectiveness July 1, 2026 and a two-year term; evaluation weighted price competitiveness at 75 percent and administrative compliance at 25 percent. The Texas HHS Commission posted RFI HHS0017013 (April 3, 2026) to explore vendor capabilities for direct-to-manufacturer prescription programs serving state pharmacy benefit objectives, indicating early-stage market research before formal RFP issuance.